RP-HPLC determination of phenylalkanoids and monoterpenoids in Rhodiola rosea and identification by LC-ESI-TOF

Biomedical Chromatography

Volumn 23, Issue 8, 2009, Pages 865-872

  Avula, Bharathi ^a   Wang, Yan Hong ^a   Ali, Zulfiqar ^a   Smillie, Troy J ^a   Filion, Vicky ^b   Cuerrier, Alain ^c   Arnason, John T ^b   Khan, Ikhlas A ^a,d  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

LC MS; LC UV; Monoterpenoids; Phenylalkanoids; Rhodiola species

Indexed keywords

MASS SPECTROMETRY; POSITIVE IONS;

LC-MS; LC-UV; LIMIT OF DETECTION; LIMIT OF QUANTIFICATIONS; MONOTERPENOIDS; PHENYLALKANOIDS; RHODIOLA; RHODIOLA ROSEA; RHODIOLUM SPECIES; RP-HPLC;

ELECTROSPRAY IONIZATION;

ALCOHOL; ASTRAGALIN; GLUCOPYRANOSIDE; KAEMPFEROL; MONGRHOSIDE; PHENYLETHYL O ALPHA ARABINOPYRANOSYL O BETA DEXTRO GLUCOPYRANOSIDE; PHENYLMETHYL O ALPHA ARABINOFURANOSYL O BETA DEXTRO GLUCOPYRANOSIDE; RHODIOLA EXTRACT; RHODIOLA ROSEA EXTRACT; ROSARIN; ROSAVIN; ROSIN; ROSIRIDINE; SACHALINOL; SALIDROSIDE; TERPENE; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; VIRIDOSIDE;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; TIME OF FLIGHT MASS SPECTROMETRY;

RHODIOLA; RHODIOLA ROSEA;

EID: 70349490281     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1198     Document Type: Article

References (20)

1. Bocharova OA, Matveev BP, Baryshnikov AI, Figurin KM, Serebriakova R and Bodrova NB. The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research). Urology and Nefrology 1995; 2: 46.
2. Furmanowa M, Skopinska-Rozewska E, Rogala E and Hartwich M. Rhodiola rosea in vitro culture - phytochemical analysis and antioxidant action. Acta Societatis Botanicorum Poloniae 1998; 67: 69-73.
3. Furmanova M, Hartwich M, Alfermann A, Kominski W and Olejnik M. Rosavin as a product of glycosylation by Rhodiola rosea (roseroot) cell cultures. Plant Cell Tissue and Organ Culture 1999; 56: 105-110.
4. Furmanowa M, Starosciak B, Lutomski J, Urbanska N, Krajewska-Patan A, Pietrosiuk A and Szypula W. Antimicrobial effect of Rhodiola rosea L. roots and callus extracts on some strains of Staphylococcus aureus. Herba Polonica 2002; 48: 23.
5. Kelly GS. Rhodiola rosea: a possible plant adaptogen. Alternative Medicine Review 2001; 6(3): 293-302.
6. Markus G, Yurdanur Y and Khan IA. Analysis of the marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography. Chemical and Pharmaceutical Bulletin 2001; 49(4): 465-467.
7. Maslowa LV, Kondratyev BY, Maslov LN and Lishmanov YB. On the cardioprotective and antiadrenergic activity of Rhodiola rosea extract during stress. Experimental and Clinical Pharmacolosy 1994; 57: 61.
8. Petkov VD, Yonkov D, Mosharoff A, Kambourova T, Alova L, Petkov VV and Todorov I. Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory. ACTA Physiologica et Pharmacologica Bulgarica 1986; 12: 3.
9. Pogorelyl VE and Makarova LM. Rhodiola rosea extract for prophylaxis of the ischemic cerebral circulation disorders. Eksperimental'naia i klinicheskaia farmakologiia 2002; 65: 19.
10. Ramazanov Z and del Mar Bernal Suarez M. In New Secrets of Effective Natural Stress and Weight Management Using Rhodiola Rosea and Rhododendron Caucasicum. ATN/Safe Goods Publishing: East Canaan, 1999; 70-75.
11. Razina TG, Zueva EP, Amosova EN and Krylova SG. Medicinal herb preparations as a means of additional therapy: Experimental oncology evidence. Eksperimental'naia i klinicheskaia farmakologiia 2000; 63: 59.
12. Sokolov S, Ivashin VM, Zapesochnaya G, Kurkin VA and Shchavlinskii AN. Studies of neurotropic activity of new compounds isolated from Rhodiola rosea. Khimiko-Farmatsevticheskii Zhurnal 1985; 19: 1367-1371.
13. Tolonen A, Pakonen M, Hohtola A and Jalonen J. Phenylpropanoid glycosides from Rhodiola rosea. Chemical and Pharmaceutical Bulletin 2003a; 51(4): 467-470.
14. Tolonen A, Hohtola A and Jalonen J. Comparison of electrospray ionization and atmospheric pressure chemical ionization techniques in the analysis of the main constituents from Rhodiola rosea extracts by liquid chromatography/mass spectrometry. Journal of Mass Spectrometry 2003b; 38: 845-853.
15. Udintsev SN and Shakov VP. Decrease of cyclophosphamide haematotoxicity by Rhodiola rosea root extract in mice with Ehrlich and Lewis transplantable tumors. European Journal of Cancer 1991a; 27: 1182.
16. Udintsev SN and Shakov VP. The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma 1991b; 38: 323.
17. Xu JF, Ying PQ, Han AM and Su ZG. Enhanced salidroside production in liquid-cultivated compact callus aggregates of Rhodiola sachalinensis: manipulation of plant growth regulators and sucrose. Plant Cell Tissue and Organ Culture 1999; 55: 53-58.
18. Yaremrnii IM and Grigoreva NF. Hepatoprotector properties of liquid extract from Rhodiola rosea. Eksperimental'naia i klinicheskaia farmakologiia 2002; 65: 57
19. Yoshikawa M, Shimada H, Shimoda H, Murakami N, Yamahara J and Matsuda H. Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. (Crassulaceae). Chemical and Pharmaceutical Bulletin. 1996; 44(11): 2086-2091.
20. Zulfiqar A, Frank RF and Khan IA. Phenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea. Planta Medica 2008; 74: 178-181.